Adalimumab/infliximabPainful cutaneous eruptions and alopecia: 7 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2017年 / 1681卷 / 1期

关键词：

D O I：

10.1007/s40278-017-39293-y

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：17 / 17

相关论文

共 50 条

[41] ApalutamideSkin eruptions: 24 case reports
Reactions Weekly, 2022, 1913 (1) : 80 - 80
[42] InterferonsGeneralised eruptions: 26 case reports
Reactions Weekly, 2014, 1532 (1) : 127 - 127
[43] ImiquimodSkin eruptions: 5 case reports
Reactions Weekly, 2007, 1182 (1) : 20 - 21
[44] EverolimusEczematous eruptions: 2 case reports
Reactions Weekly, 2019, 1780 (1) : 160 - 160
[45] SorafenibSkin eruptions: 4 case reports
Reactions Weekly, 2009, 1245 (1) : 35 - 35
[46] DocetaxelSkin eruptions: 2 case reports
Reactions Weekly, 2009, 1242 (1) : 21 - 21
[47] InfliximabPsoriasiform eruptions: 3 case reports
Reactions Weekly, 2006, 1131 (1) : 22 - 22
[48] Cemiplimab/ipilimumab/nivolumabBlistering cutaneous eruptions, lichenoid dermatosis and epidermal necrolysis: 4 case reports
Reactions Weekly, 2022, 1908 (1) : 155 - 155
[49] TelaprevirSkin eruptions: 8 case reports
Reactions Weekly, 2017, 1633 (1) : 665 - 665
[50] ModafinilSkin eruptions: 2 case reports
Reactions Weekly, 2008, 1231 (1) : 22 - 22

← 1 2 3 4 5 →